In 2017 many exceptional projects from our partners reached important milestones, amongst them potential diagnostics and therapeutics as well as platform technologies e.g. for imaging. We make the successful achievement of these milestones transparent, showing the step-by-step transfer of research results towards application – for the benefit of patients.
A major focus of our work in 2017 was supporting spin-offs. This field will become more prominent in the future, a reason why we dedicate ourselves to establish transparent standards for equity and licence agreements – together with the TechnologieAllianz, investors, governmental departments, founders and other technology transfer organizations.
For our 30 partners we have
- evaluated 111 invention disclosures and managed 53 patent applications
- provided extensive support for 18 start-up projects and several technology development projects
- raised EUR 6.22 million in funding for translational development
- acquired equity in 2 companies and sold 1 portfolio company/shareholding
- distributed EUR 1.6 million to the LifeScience Foundation, mostly from the sale of equity
- negotiated 58 agreements with industry that have generated a total of EUR 8.05 million in revenues for our partners.
In 2017, products, based on contributions from our partners, have generated a total turnover of EUR 1.85 billion, and our portfolio companies employed 325 staff.
Browse through the report! In addition to our figures and infographics, you can also find exciting examples of projects that demonstrate the potential benefit of our partners’ work to society.